The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Ibuprofen Interferes with the Efficacy of Antihypertensive Drugs: A Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Compared with Acetaminophen
Abstract
Study Objective: To assess the effects of Ibuprofen on blood pressure control in patients being treated with antihypertensive drugs. Design: Randomized, blinded, placebo-controlled, parallel trial of Ibuprofen compared with acetaminophen and with placebo in 3-week treatment periods. Setting: A general internal medicine clinic at a university hospital. Patients: Forty-five patients with essential hypertension controlled by treatment with at least two antihypertensive drugs were enrolled. Of these, 41 completed the study; treatment was discontinued in 3 of the 15 patients in the Ibuprofen group due to breakage of the drug capsules, and after randomization in 1 of the 14 patients in the placebo group due to unstable angina. All 15 patients in the acetaminophen group completed the study. Interventions: All previous antihypertensive regimens were continued. During the 3-week treatment, Ibuprofen, 400 mg, was administered orally every 8 hours; acetaminophen, 1 g, orally every 8 hours; or placebo, 2 capsules, orally every 8 hours. Measurements and Main Results: In the Ibuprofen group, the mean increase from baseline after 3 weeks of treatment was significant in the average supine diastolic blood pressure (6.4 mm Hg; 95% confidence interval [Cl], 1.05 to 11.75; p = 0.0239); supine mean arterial pressure (6.6 mm Hg; 95% Cl, 1.25 to 11.95; & p = 0.0205); and sitting mean arterial pressure (5.8 mm Hg; 95% Cl, 1.57 to 10.04; p = 0.0123). The mean increase in blood pressure variables in the Ibuprofen group was significantly different compared with the mean increase in the variables in the placebo group after 3 weeks of treatment: supine systolic blood pressure (7.1 mm Hg compared with -4.5 mm Hg; 95% Cl for the difference in means, 2.5 to 20.6; p = 0.0133); supine diastolic pressure (6.4 mm Hg compared with 0.0; 95% Cl for difference in means, 0.87 to 12.4; p = 0.0250); supine mean arterial pressure (6.6 mm Hg compared with -1.5; 95% Cl for difference in means, 2.0 to 14.2; p= 0.0110); sitting systolic pressure (6.8 mm Hg compared with -3.7; 95% Cl for difference in means, 2.0 to 19.0; p = 0.0169); sitting diastolic pressure (5.3 mm Hg compared with -1.1; 95% Cl for difference in means, 0.76 to 12.1; p = 0.0273); and sitting mean arterial pressure (5.8 mm Hg compared with -2.0; 95% Cl for difference in means, 1.5 to 14.1; p = 0.0169). When compared with the acetaminophen group after 3 weeks of treatment, the Ibuprofen group also showed statistically significant changes in supine diastolic and mean arterial pressures, and sitting diastolic and mean arterial pressures. Conclusions: Ibuprofen can interfere with blood pressure control in certain patients with treated mild-to-moderate hypertension. Further clinical studies are needed to document these findings and determine which patients are most likely to have an ibuprofen-related impairment in blood pressure control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, NSAIDs affect the treatment effect of several antihypertensive medication classes, including diuretics, ACE inhibitors, ARBs, and β-blockers.184,185”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [184]
Citations
Cites
Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
Clive, D. M., & Stoff, J. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403013100905 · Cited by 1,127
Effects of Sulindac and Ibuprofen in Patients with Chronic Glomerular Disease
Ciabattoni, G., Cinotti, G. A., Pierucci, A., Simonetti, B. M., Manzi, M., Pugliese, F. R., Barsotti, P., Pecci, G., Taggi, F., & Patrono, C. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402023100502 · Cited by 329
Antagonism of the effects of furosemide by in domethacin in normal and hypertensive man
Patak, R. V., Mookerjee, B. K., Bentzel, C. J., Hysert, P., Babej, M., & Lee, J. B. (1975) · Prostaglandins · doi:10.1016/s0090-6980(75)80012-8 · Cited by 264
Arachidonic acid metabolism, prostaglandins and the kidney
Levenson, D. J., Simmons, C. E., & Brenner, B. M. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90826-9 · Cited by 224
Garella, S., & Matarese, R. A. (1984) · Medicine · doi:10.1097/00005792-198405000-00003 · Cited by 221
Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin.
Watkins, J. B., Abbott, E., Hensby, C. N., Webster, J., & Dollery, C. T. (1980) · BMJ · doi:10.1136/bmj.281.6242.702 · Cited by 181
Kirkendall, W. M., Feinleib, M., Freis, E. D., & Mark, A. L. (1980) · PubMed · Cited by 171
Durão, V., Prata, M. M., & Gonçalves, L. M. P. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92899-9 · Cited by 142
Dg, W., LAMKI, L. M., Spence, J. D., Freeman, D., & McDonald, J. W. D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91271-7 · Cited by 126
Chalmers, J. P., West, M., Wing, L. M. H., Bune, A. J. C., & Graham, J. R. (1984) · Clinical and Experimental Hypertension · doi:10.3109/10641968409039582 · Cited by 88
Research works printed but not linked: 12
- LOPEZ-OVEJERO J, 1978, Clin Sci Mol Med., 55, 203s
- CHALMERS J, 1984, Clin Exper Hypertens [A]., 6, 1077
- EBEL D, 1985, Advances in Therapy, 2, 131
- REGESTER R, 1980, J Tenn Med Assoc., 73, 709
- LEE R, 1983, Can Med Assoc J, 129, 854
- POIRIER T, 1984, Drug Intell Clin Pharm., 18, 2732
- RADACK K, 1987, J Gen InMed., 2, 108
- KIRKENDALL W, 1980, Circulation., 62, 1146A
- COHEN E, 1971, J Lab Clin Med., 77, 1025
- DANIEL W . Biostatistics: A Foundation for Analysis in the Health Sciences. 3rd ed. New York: Wiley and Sons; 1983;411-6.
- LINTON A, 1984, Can Med Assoc J., 131, 189
- LEVENSON D, Kidney Int., 1980, 609
Cited by
Sorted by citations
Items 101–140 of 140
Bennett, W. M. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0829-4_15 · Cited by 3
Over-the-counter drugs that may increase blood pressure
Prisant, L. M., & Carr, A. A. (1989) · Postgraduate Medicine · doi:10.1080/00325481.1989.11704509 · Cited by 3
Prescott, L. F. (1998) · Springer eBooks · doi:10.1007/978-94-011-4878-8_1 · Cited by 2
Hipertensión arterial en las enfermedades autoinmunes y sistémicas
Sierra, C. (2005) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(05)71523-3 · Cited by 2
Ferdinand, K. C., Giles, T. D., Falkner, B. E., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Calhoun, A. W., Jones, D. W., Textor, S. C., et al. (2008) · Cited by 2
Nonprescription Drug Review: Ibuprofen-A Monograph
Dg, A. (1991) · American Pharmacy · doi:10.1016/s0160-3450(16)33657-1 · Cited by 2
Ibuprofen and Antihypertensive Drugs
Miller, L. G. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-485_1 · Cited by 2
Emergencia hipertensiva secundaria a la toma de AINE
Angulo, A. H. (2004) · Atención Primaria · doi:10.1016/s0212-6567(04)70849-5 · Cited by 2
Hipertensión arterial en las enfermedades autoinmunes y sistémicas
Sierra, C. (2005) · Hipertensión · doi:10.1016/s0212-8241(05)74811-8 · Cited by 2
Drug Therapy for the Patient With Resistant Hypertension
Donazzan, L., Ewen, S., Papademetriou, V., Linicus, Y., Linz, D., Böhm, M., & Mahfoud, F. (2015) · Future Cardiology · doi:10.2217/fca.15.9 · Cited by 1
Follow-up of Patients with Resistant Hypertension
Kallistratos, M. S., Pavlidis, A. N., & Manolis, A. J. (2013) · Springer eBooks · doi:10.1007/978-88-470-5415-8_14 · Cited by 1
Aspirin as an Independent Risk Factor for Hypertension
Sanyaolu, A. O., Hammoudi, D., Meer, K., Zulfiqar, S., Varghese, N., Holmes, B., Pandit, R., & Sanyaolu, A. (2024) · Bioequivalence & Bioavailability International Journal · doi:10.23880/beba-16000233 · Cited by 1
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND HYPERTENSION – DOES AN EXEPTION CHANGE THE RULE?
Velickovic, D., Đukić, D., & Tasić, D. (2014) · Acta Medica Medianae · doi:10.5633/amm.2014.0304 · Cited by 1
Paracetamol (acetaminophen) and combinations
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01223-3 · Cited by 1
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.00873-8 · Cited by 1
Nguyen, Q.-V. (2011) · Circulation · doi:10.1161/circulationaha.110.015586 · Cited by 1
Ibuprofen and Antihypertensive Drugs
Furey, S. A. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-4-645 · Cited by 1
Calhoun, D. A. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-0258-5.50149-6 · Cited by 1
Non-steroidal anti-inflammatory drugs (NSAIDs)
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/01280-8 · Cited by 1
Therapeutic Interventions in the Treatment of Acute and Chronic Pain in Osteoarthrosis
Moskowitz, R. W. (1988) · Springer eBooks · doi:10.1007/978-3-642-73878-4_7 · Cited by 1
Semplicini, A., Stella, F., & Ceolotto, G. (2012) · InTech eBooks · doi:10.5772/30352
PREDNOSTI PARACETAMOLA U LIJEČENJU OSOBA S HIPERTONIJOM I ARTROZOM
Pavličević, I., Kuzmanić, M., Rumboldt, M., & Rumboldt, Z. (2011) · University of Zagreb University Computing Centre (SRCE)
Interacciones de drogas anti-hipertensivas
Acuña, F. P. (2008) · Revista Latinoamericana de Hipertensión/Revista Latinoamericana de Hipertensiòn
¿Interfiere en el control de la HTA el consumo de paracetamol en formulaciones solubles?
Camps, M. B., Boreu, Q. F., Llibre, J. B., & de Tuero, G. C. (2010) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2009.03.003
Nonsteroidal Anti-Inflammatory Drugs, and Hypertension
Kisch, E. S., Fischel, B., & Yaron, M. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-4-344_1
Resistant Hypertension: Etiology, Evaluation and Management
Olafiranye, O., Mahmud, S., Zizi, F., McFarlane, S. I., Jean‐Louis, G., & Ogedegbe, G. G. (2012) · Humana Press eBooks · doi:10.1007/978-1-60327-357-2_6
Giles, T. D., Falkner, B. E., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., Ferdinand, K. C., Calhoun, D. A., Jones, D. W., Textor, S. C., et al. (2013)
The role of TRPM2 channels in oxidative stress-induced liver damage.
Kheradpezhouh, E. (2015) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
ANTIHYPERTENSIVE DRUGS COMPROMISED BY IBUPROFEN.
Cer (1987) · Journal watch · doi:10.1056/jw198712010000004
Nishizaka, M., & Calhoun, D. A. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3358-5.50042-5
BLOOD PRESSURE INCREASES INDUCED BY IATROGENESIS, OVER THE COUNTER SUBSTANCES, AND HERBALS PRODUCTS
Wang, S., & Sander, G. E. (2021) · Medical Research Archives · doi:10.18103/mra.v9i5.2394
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/01220-1
Rainsford, K. D. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0496-7_8
Anti-inflammatory and antipyretic analgesics and drugs used in gout
Favero, A. D. (2004) · Side effects of drugs annual · doi:10.1016/s0378-6080(04)80016-3
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/01264-x
SALICYLATES, PARACETAMOL, AND OTHER NON-OPIOID ANALGESICS
(2010) · Elsevier eBooks · doi:10.1016/b978-0-444-53273-2.50005-5
Anti-inflammatory analgesics and drugs used in rheumatoid arthritis and gout
Favero, A. D. (1989) · Side effects of drugs annual · doi:10.1016/s0378-6080(89)80015-7
ADVERSE CARDIOVASCULAR EFFECTS OF NON-CARDIOVASCULAR DRUGS
(2009) · Elsevier eBooks · doi:10.1016/b978-0-444-53268-8.50009-0
NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs)
(2010) · Elsevier eBooks · doi:10.1016/b978-0-444-53273-2.50006-7
Effect of paracetamol on blood pressure and comparison with NSAIDs
Prokeš, M., & Suchopár, J. (2024) · Medicína pro praxi · doi:10.36290/med.2024.030
Metadata
- Authors
- RADACK, K. L., DECK, C. C., & BLOOMFIELD, S. S.
- Affiliations
- University of Cincinnati (US)
- Cincinnati, Ohio
- Corresponding author
- RADACK, KENNETH L
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1987-11-01
- Volume
- 107
- Issue
- 5
- Pages
- 628-635
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1973757442
- Cited by
- 140
- References
- 27
- Citations by year
- 2024: 2 · 2023: 2 · 2022: 3 · 2021: 1 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 8 · 2014: 3 · 2013: 5 · 2012: 8
- FWCI
- 7.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- ibuprofen, antihypertensive drugs, essential hypertension, drug interactions, blood pressure control, paracetamol, nonsteroidal anti-inflammatory drugs, diastolic blood pressure, mean arterial pressure, combination therapy, adverse drug reactions, drug discontinuation, angina pectoris
- MeSH terms
- Acetaminophen, Adrenergic beta-Antagonists, Adult, Aged, Antihypertensive Agents, Blood Pressure, Clinical Trials as Topic, Double-Blind Method, Female, Humans, Hypertension, Ibuprofen, Male, Middle Aged, Random Allocation, Renin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review